CDC Opens a $1.26 Billion Cancer Prevention Recompete With a Tribal Lane Written Into Statute

Tribal health organizations, Urban Indian programs, and the community-based coalitions that partner with them now have a $1.26 billion target and a February 5, 2027 deadline: CDC posted CDC-RFA-DP-27-0023 to Grants.gov on September 3, 2026, opening the recompete of its combined cancer prevention and control portfolio.

What CDC-RFA-DP-27-0023 Actually Funds

The Grants.gov listing for opportunity 363814 is not one program. It is three, bundled into a single cooperative agreement announcement under Assistance Listing 93.898, and the bundling is the single most important structural fact for anyone deciding whether to apply.

Program 1 is the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Component A pays for breast and cervical cancer screening and diagnostic follow-up for women with low incomes who lack adequate insurance. Component B — explicitly optional — funds evidence-based interventions to raise screening rates in the clinics serving those women.

Program 2 is the National Comprehensive Cancer Control Program (NCCCP), which funds coalition work: planning and implementing the evidence-based strategies laid out in a jurisdiction-wide cancer plan.

Program 3 is the National Program of Cancer Registries (NPCR), supporting population-based central cancer registries.

CDC's own framing in the synopsis is that the three only work at full strength together — that "by the three programs working together through partnerships, coordination of resources and efforts, consistent communication, and community involvement," the division moves toward its stated mission of "All People Free of Cancer." That is not decorative language. It is a signal about how reviewers will read applications that treat screening, coalition strategy, and surveillance as separable line items.

The headline numbers: estimated total program funding of $1,260,000,000 across an anticipated 196 awards. Applications close at 11:59 p.m. ET on February 5, 2027, and the opportunity archives March 7, 2027. Questions route to Netta Apedoe, MPH, at DP270023@cdc.gov.

The Tribal Lane Is Written Into Statute, Not Left to Discretion

Most federal health NOFOs mention tribal eligibility somewhere in a list and then bury it. This one carries it in the title, and the eligibility text explains why: tribal access here is statutory.

For Program 1, CDC states that funds "will be awarded to state health departments and the District of Columbia; US Territories and Freely Associated States, Federally Recognized American Indian Tribes, Tribal Organizations, Alaska Native Organizations, and Urban Indian Organizations, or their Bona Fide Agents," and points directly at the authorizing statute — the Breast and Cervical Cancer Mortality Prevention Act, at 104 Stat. 409. Eligibility is limited by law, and tribal entities are inside the limit by name.

Program 3 runs the other way. NPCR eligibility is capped by the Cancer Registries Amendment Act to state governments, DC, territories and freely associated states, and their bona fide agents. A tribal organization cannot lead a registry application. That asymmetry is worth internalizing before anyone spends a week on a concept paper: the registry money is not the tribal money.

The eligible applicant types on the listing reinforce the point. Federally recognized tribal governments and tribal organizations other than federally recognized tribal governments are both listed, alongside 501(c)(3) nonprofits, nonprofits without 501(c)(3) status, county and city or township governments, and public and private institutions of higher education. A community-based organization without IRS determination is not automatically excluded from this competition — a genuinely unusual posture for a CDC chronic disease award of this size.

The Bona Fide Agent Clause Is the Real Entry Point for CBOs

The phrase "or their Bona Fide Agents" appears in both statutory eligibility paragraphs, and it is the most under-read sentence in the announcement.

A bona fide agent applies on behalf of an eligible entity — a state, a territory, a tribe — and CDC requires documentation demonstrating that arrangement. For a rural, tribal, or faith-based organization that is already the operational backbone of screening navigation or coalition convening in its region, this is the mechanism that converts existing work into a named role on a federal application rather than a subaward negotiated after the fact.

It is also the piece with the longest lead time. Securing a bona fide agent designation means getting a tribal council resolution, a health department letter, or a formal delegation on paper — governance work that runs on quarterly meeting calendars, not grant calendars. With the deadline five months out, an organization that starts the designation conversation in September has room. One that starts in December is asking a council to move at a speed councils do not move.

Read the Blank Award Ceiling Carefully

CDC left both the award ceiling and the award floor blank on this listing. That is not an oversight; it reflects a competition where a single announcement spans three programs and 196 awards across jurisdictions of wildly different size.

The arithmetic is tempting and misleading. If $1.26 billion is spread across 196 awards over a project period matching the predecessor's five years, the average lands near $6.4 million per award total, or roughly $1.3 million a year. But averages across this portfolio mean very little. A large state health department running NBCCEDP Component A clinical services at scale, plus a registry, plus coalition work, sits at one end. A tribal organization applying for NCCCP coalition support sits at the other. Building a budget from the average is the fastest way to submit a number that signals you did not understand the structure.

The predecessor NOFO, CDC-RFA-DP22-2202, ran as a five-year announcement and funded 66 recipients. CDC currently reports NCCCP support reaching all 50 states and DC, 8 territories and freely associated states, and 7 tribes and tribal organizations. That last figure — seven — is the one tribal applicants should sit with. It is small enough that the field is genuinely contestable and large enough to prove the pathway is real.

One more line item that applicants skip at their peril: cost sharing is marked required on this opportunity. Not encouraged, not optional. Match strategy — in-kind clinical time, coalition staff effort, tribal general funds, partner contributions — needs to be documented, not improvised in January.

A Five-Month Runway Is the Competitive Advantage

The window here is unusually generous by federal standards, and that changes what a good application looks like.

We have written before about the opposite case — FEMA compressing $420 million in emergency management grants into a single 30-day window, where the only organizations that competed were the ones already holding a finished draft. CDC's 155-day runway is the inverse problem. When everyone has time, time stops being a differentiator and the quality of the underlying partnership structure becomes the differentiator instead.

That means the things worth spending September and October on are not narrative drafting. They are: confirming which of the three programs your organization is actually eligible to lead versus support; getting the bona fide agent documentation in motion; and pulling your jurisdiction's current cancer plan to find where your organization's work already maps to a named strategy in it. NCCCP applications are evaluated against jurisdiction-wide cancer plans. If your service area's plan does not mention the population you serve, that gap is your strongest argument — and it takes months, not weeks, to get a coalition to acknowledge it in writing.

For coalitions in rural and tribal regions, the surveillance angle deserves attention even though NPCR leadership is off the table. Registry data is what makes a burden argument credible, and organizations that can articulate specifically where registry coverage undercounts their community — late-stage diagnosis rates, incomplete race and ethnicity coding, referral loss between screening and diagnostic follow-up — are describing exactly the coordination failure this NOFO says it exists to fix.

What to Do Before the End of September

Three concrete moves, in order of lead time.

First, decide your role. Lead applicant, bona fide agent, or named partner on someone else's application are three different documents with three different governance requirements. Pick one this month.

Second, if the answer involves bona fide agent status, get the request onto a council or health department agenda now.

Third, pull the last five years of comparable federal cancer awards in your state to see who has been funded, at what scale, and where the gaps sit. That history tells you whether you are competing against an incumbent or filling an empty seat.

Search active cancer prevention and tribal health funding on Granted — start with cancer prevention and tribal health opportunities to see what else is open alongside DP-27-0023, and which funders in your state have backed comprehensive cancer control coalitions before.